S A Grampsas

Suggest Changes
Learn More
OBJECTIVE A phase I/II study was initiated in patients with refractory localized superficial bladder cancer to establish the tolerance and toxicity of recombinant tumor necrosis factor (rTNF) given(More)
  • 1